CELZ · Creative Medical Technology Holdings Inc. Common Stock
View on chartInsiders & Stakes
| Warbington Timothy President & CEO | ▲ Buy | Grant | 1,034,904 Shares held | 9/24/2026 | View profile |
| Finger Michael H. | ▼ Sell | Open Market | 351 Shares held | 2/19/2025 | View profile |
Transaction History
| Warbington Timothy | ▲ Buy | Grant | 1,000,000 | — | 9/24/2026 |
| Finger Michael H. | ▼ Sell | Open Market | 750 | $4K | 2/19/2025 |
| Finger Michael H. | ▼ Sell | Open Market | 750 | $4K | 2/18/2025 |
| Warbington Timothy | ▲ Buy | Open Market | 200 | $872 | 6/28/2023 |
| Warbington Timothy | ▲ Buy | Open Market | 300 | $1K | 6/27/2023 |
| Warbington Timothy | ▲ Buy | Open Market | 200 | $896 | 6/27/2023 |
| Warbington Timothy | ▲ Buy | Open Market | 300 | $1K | 6/27/2023 |
| Warbington Timothy | ▲ Buy | Open Market | 9,800 | $4K | 11/22/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 200 | $75 | 11/22/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 10,000 | $4K | 11/21/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 5,000 | $2K | 11/21/2022 |
| Finger Michael H. | ▲ Buy | Open Market | 2,000 | $1K | 9/27/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 20,000 | $10K | 9/27/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 12,000 | $6K | 9/22/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 5,000 | $3K | 9/21/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 4,500 | $3K | 9/21/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 500 | $314 | 9/21/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 20,000 | $12K | 9/21/2022 |
| Finger Michael H. | ▲ Buy | Open Market | 10,000 | $7K | 6/14/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 2,000 | $2K | 6/6/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 8,000 | $7K | 6/6/2022 |
| Warbington Timothy | ▲ Buy | Open Market | 15,000 | $14K | 6/6/2022 |
| Finger Michael H. | ▲ Buy | Open Market | 6,500 | $10K | 5/20/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
CELZ raises BioDefense stake to 80% with $200K cash and share purchase
Creative Medical Technology announced it has purchased an additional 4 million BioDefense shares for $200,000 in cash and 1 million of its own shares. The transaction raises Creative’s ownership of BioDefense to about 80 percent. The increased stake may broaden Creative’s product portfolio and could influence future earnings.
CELZ raises BioDefense stake to 80% with $200K cash and share purchase. Creative Medical Technology announced it has purchased an additional 4 million BioDefense shares for $200,000 in cash and 1 million of its own shares. The transaction raises Creative’s ownership of BioDefense to about 80 percent. The increased stake may broaden Creative’s product portfolio and could influence future earnings.